|
1. Biologie
|
|
|
|
2.6 Etiologie - Environnement
|
|
|
|
3.1 Tabac
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
2015
Market Segmentation Analysis of the Global Cancer Diagnostics Industry:
Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones,
Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
[ResearchAndMarkets]
|
|
|
|
|
|
During
the next five years, the worldwide cancer diagnostics market is
promising to be an exciting, dynamic and rapidly expanding field.
Anticipated technological breakthroughs will create numerous
opportunities for determining genetic predisposition, detecting specific
tumors, and monitoring biological response to cancer therapy.
|
|
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
A decade of discovery in cancer genomics [Cancer World]
|
|
|
|
|
|
Over
the past decade, genetic testing for rare inherited mutations, such as
BRCA1 and BRCA2 mutations, has been successfully incorporated into
clinical practice. Next-generation sequencing of cancer-susceptibility
genes and entire tumour genomes has transformed cancer care and
prevention. The discoveries of new cancer syndromes have raised exciting
opportunities and potential liabilities for cancer-care providers
seeking to incorporate genomic approaches into preventive oncology
practice.
|
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
|
5. Traitements
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
6.11 Patients
|
|
|
Living With Cancer: Being Mortal [NY Times]
|
|
|
|
|
|
Like
many people with advanced-stage cancer, I wonder when I will decide
about treatment, “Enough is enough.” In helping me formulate an answer
to this question, Atul Gawande’s latest book, “Being Mortal,” will now
play an indispensable part.
|
|
|
|
|
|
|
6.4 Médico-éco
|
|
|
|
|
|
6.6 Publications
|
|
|
Feature: Cancer reproducibility effort faces backlash [Science]
|
|
|
|
|
|
For
many scientists, the biggest concern is the nature of the labs that
will conduct the replications. It's unrealistic to think contract labs
or university core facilities can get the same results as a highly
specialized team of academic researchers, they say.
|
|
|
|
|
|
|
|
|
6.9 Controverses
|
|
|